PND26 The Cost-Effectiveness of Fremanezumab in Patients with Migraine Who Have Failed Two or More Previous Migraine Preventive Therapies From a UK Healthcare System Perspective
Abstract
Authors
A. Skroumpelos M. Freddi H. Akcicek J. Cohen M.T. Driessen